119 related articles for article (PubMed ID: 35151203)
1. MS4A15 acts as an oncogene in ovarian cancer through reprogramming energy metabolism.
Fang Y; Yu H; Zhou H
Biochem Biophys Res Commun; 2022 Apr; 598():47-54. PubMed ID: 35151203
[TBL] [Abstract][Full Text] [Related]
2. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
3. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
4. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway.
Zhao J; Zhang X; Gao T; Wang S; Hou Y; Yuan P; Yang Y; Yang T; Xing J; Li J; Liu S
Cell Death Dis; 2020 Jan; 11(1):25. PubMed ID: 31932581
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
7. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract][Full Text] [Related]
8. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
9. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
[TBL] [Abstract][Full Text] [Related]
10. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.
Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L
Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864
[No Abstract] [Full Text] [Related]
11. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
13. Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184.
Hou W; Zhang Y
Pathol Res Pract; 2021 Jan; 217():153275. PubMed ID: 33285422
[TBL] [Abstract][Full Text] [Related]
14. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
[TBL] [Abstract][Full Text] [Related]
15. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
Yuan S; Xu Y; Yi T; Wang H
J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
[TBL] [Abstract][Full Text] [Related]
16. Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer.
Zhang C; Ni X; Tao C; Zhou Z; Wang F; Gu F; Cui X; Jiang S; Li Q; Lu H; Li D; Wu Z; Zhang R
Cell Oncol (Dordr); 2024 Feb; 47(1):157-174. PubMed ID: 37632669
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway.
Zhang J; Wang L; Jiang J; Qiao Z
J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285
[TBL] [Abstract][Full Text] [Related]
18. CDCA3 exhibits a role in promoting the progression of ovarian cancer.
Gong S; Bai B; Sun G; Jin H; Zhang Z
Tissue Cell; 2022 Dec; 79():101903. PubMed ID: 36081320
[TBL] [Abstract][Full Text] [Related]
19. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
[TBL] [Abstract][Full Text] [Related]
20. Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells
Ruan Z; Zhao D
FASEB J; 2019 Nov; 33(11):12047-12059. PubMed ID: 31574234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
